1-1 of 1
Michael T. Cullen, Jr., MD
Close
Sort by
Journal Articles

Phase II Study of Low-Dose Decitabine for the Front-Line Treatment of Older Patients with Acute Myeloid Leukemia (AML).

Amanda Cashen, MD, Gary J. Schiller, MD, Julie S. Larsen, PharmD, Michael T. Cullen, Jr., MD, John F. DiPersio, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 1984.
https://doi.org/10.1182/blood.V108.11.1984.1984
Published: 2006